AP
CLOV icon

Atlas Principals’s Clover Health Investments CLOV Stock Holding History

Atlas Principals’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-77,500
Closed -$966K – 37
2020
Q3 		$966K Buy
+77,500
New +$858K 0.49% 33

Other funds holding CLOV

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Atlas Principals's CLOV Position: Q4 2020 in Review

Atlas Principals sold out of Clover Health Investments (CLOV) in Q4 2020, closing a stake of 77,500 shares — an estimated $966K sold.

Atlas Principals first reported a position in CLOV in Q3 2020 and held it in 1 quarter. The position peaked at $966K in Q3 2020. 93 funds tracked by Wall St. Rank hold CLOV as of Q4 2020.

  • Atlas Principals reported no remaining Clover Health Investments position as of Q4 2020 after selling out during the quarter.
  • Atlas Principals sold 77,500 Clover Health Investments shares in Q4 2020, an estimated $966K.
  • Atlas Principals first reported a position in Clover Health Investments in Q3 2020 and held it in 1 quarter.
  • Atlas Principals's Clover Health Investments position peaked at $966K in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2020.

Based on Atlas Principals's 13F filing for Q4 2020, filed 16 Feb 2021.